Evidence map›Paper›PMID 35117172›Full record

ArticleTranslational cancer research2020

The overexpression of ZWINT in integrated bioinformatics analysis forecasts poor prognosis in breast cancer.

Ming-Tao Shao, Yang-Zhi Hu, Hui Ding, Qing Wu, Jing-Hua Pan, Xiao-Xu Zhao, Yun-Long Pan

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ming-Tao ShaoDepartment of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
Yang-Zhi HuDepartment of Gastrointestinal Surgery, The Affiliated Hospital of Xiangnan University, Chenzhou 423000, China.
Hui DingDepartment of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
Qing WuDepartment of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
Jing-Hua PanDepartment of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
Xiao-Xu ZhaoDepartment of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
Yun-Long PanDepartment of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
First Affiliated Hospital of Jinan University · CNJiangmen Central Hospital · CNXiangnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZeste White 10 interactor (ZW10 interactor, ZWINT) is a centromeric complex required for a mitotic spindle checkpoint. According to previous studies, it was overexpressed in people with recurrent tumors. However, the expression of ZWINT in breast cancer has not been thoroughly studied. In addition, the correlations of ZWINT to prognosis in breast cancer remain unclear.

methodsIn this study, the expression of ZWINT in different types of tumors was analyzed based on the Oncomine database, and the effect of ZWINT expression on clinical prognosis was evaluated by Kaplan-Meier plotter.

resultsIn breast cancer, lung cancer, sarcoma, ovarian cancer, bladder cancer, liver cancer and cervical cancer, the expression of ZWINT was higher than that in normal tissues, but in gastric cancer, prostate cancer, myeloma, renal cancer and pancreatic cancer, the expression of ZWINT was lower. In addition, a meta-analysis of 22 cancer database studies found that the ZWINT gene was over-expressed in breast cancer tissues compared with normal tissues (P=4.05×10

conclusionsOur results strongly suggest that over expression of ZWINT is closely related to poor prognosis of breast cancer. ZWINT may be a prognostic biomarker for the treatment of BC.

Indexed as

bioinformatics analysisbiomarkerbreast cancerZWINT

Identifiers

PMID35117172
PMCPMC8798864
OpenAlexW2998168282

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.